<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Circulating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA (ctDNA) is a promising biomarker in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: We generated <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft models</z:e> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and detected ctDNA in plasma by qRCR targeting human AluJ sequences </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Our assay reached single cell sensitivity in vitro and a correlation between ctDNA amount and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size was observed in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with a <z:chebi fb="0" ids="52290">mitogen</z:chebi> activated protein kinase kinase (MEK)-inhibitor (BAY 869766) reduced ctDNA levels </plain></SENT>
<SENT sid="4" pm="."><plain>Using this assay, we also confirmed that high levels of cell-free DNA are found in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients compared to healthy individuals </plain></SENT>
<SENT sid="5" pm="."><plain>DISCUSSION AND CONCLUSION: We show that ctDNA may be useful biomarker for monitoring <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and treatment response </plain></SENT>
</text></document>